Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Antineoplaston Therapy in Treating Patients With Recurrent or Stage IV Lung Cancer

This study is ongoing, but not recruiting participants.
Sponsor:
Information provided by:
National Cancer Institute (NCI)
ClinicalTrials.gov Identifier:
NCT00003494
First received: November 1, 1999
Last updated: July 23, 2008
Last verified: April 2004
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: No date given
  Estimated Primary Completion Date: No date given